Revenue issues second-biggest tax demand by State to pharma giant

An Irish based pharmaceutical company has been issued with a €1.6bn tax bill by The Revenue Commissioner.

Revenue issues second-biggest tax demand by State to pharma giant

Revenue has issued a tax bill of €1.6b to a major pharmaceutical company.

The assessment is the second largest in Irish history after Apple was ordered to pay €13bn in 2016.

The tax bill served on Dublin-based pharma company Perrigo relates to Elan, a company that was bought by Perrigo five years ago.

Elan sold its interests in a multiple sclerosis drug in 2013 to a company called Biogen for an up-front payment of $3.25bn and a share of future royalties.

According to the Irish Times, the company said that taxes were paid on the profits from the transaction at the corporation tax rate of 12.5%.

However, Revenue argues that Elan was liable at the capital gains tax rate of 33%.

Perrigo has said it disagrees with Revenue and intends to contest the bill.

More in this section

IE_180_logo
Price info

Subscribe to unlock unlimited digital access.
Cancel anytime.

Terms and conditions apply

Puzzles logo
IE-logo

Puzzles hub

Visit our brain gym where you will find simple and cryptic crosswords, sudoku puzzles and much more. Updated at midnight every day. PS ... We would love to hear your feedback on the section right HERE.

Puzzles logo
IE-logo

Puzzles hub

Visit our brain gym where you will find simple and cryptic crosswords, sudoku puzzles and much more. Updated at midnight every day. PS ... We would love to hear your feedback on the section right HERE.